Genetic Engineering & Biotechnology News Reports On Cancer Biomarkers

Biotechnology companies are focusing on the development of novel biomarkers to overcome the limitations of current diagnostic tests for cancer, reports Genetic Engineering and Biotechnology News (GEN). To effectively move cancer therapy forward, a much stronger and targeted emphasis on diagnosis will be required, according to an article in the April 1 issue of GEN (http://www.genengnews.

More: continued here

Filed under: Cancer on April 2nd, 2008